HMG-1 as a late mediator of endotoxin lethality in mice

Area of Science:

• Immunology and Molecular Medicine
• Bacterial Pathogenesis and Host Response

Background:

• Gram-negative bacteria endotoxins trigger macrophage release of tumor necrosis factor (TNF) and interleukin-1 (IL-1).
• These early mediators can cause tissue injury and lethal shock (endotoxemia).
• Therapeutic strategies targeting TNF and IL-1 have shown limited clinical success, suggesting the involvement of other pathogenic factors.

Purpose of the Study:

• To identify and characterize potential late mediators contributing to endotoxin-induced lethality.
• To investigate the role of High Mobility Group-1 (HMG-1) protein in the pathogenesis of endotoxemia.

Main Methods:

• Macrophage cultures were stimulated with endotoxin, TNF, or IL-1 to assess HMG-1 release kinetics.
• Serum HMG-1 levels were measured in mice following endotoxin exposure over a 32-hour period.
• The efficacy of anti-HMG-1 antibodies and HMG-1 administration was evaluated in a mouse model of endotoxemia.

Main Results:

• HMG-1 protein release by macrophages occurred more than 8 hours after stimulation with endotoxin, TNF, or IL-1.
• Elevated serum HMG-1 levels were observed in mice between 8 and 32 hours post-endotoxin exposure.
• Delayed administration of anti-HMG-1 antibodies significantly reduced endotoxin-induced lethality in mice.
• Direct administration of HMG-1 proved lethal in the mouse model.

Conclusions:

• HMG-1 acts as a late-acting mediator in endotoxin-induced lethality.
• Targeting HMG-1 therapeutically may offer a novel strategy for treating endotoxemia.
• Elevated HMG-1 levels in septic patients who succumbed to infection support its role in human sepsis.